Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: development, validation and severity strata of the cNF-PUSH-D

Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: Development and validation of the Nef-ASI

Refined genotype-phenotype correlations in neurofibromatosis type 1 patients with NF1 point variants

A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials

Comment on Intragenic inversions in NF1 gene as pathogenic mechanism in neurofibromatosis type 1

Neurofibromatosis type 1: Factors associated with flare-ups of cutaneous neurofibromas at puberty

cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults

Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort

Bone Status According to Neurofibromatosis Type 1 Phenotype: A Descriptive Study of 60 Women in France

Lymphoproliferative malignancies in patients with neurofibromatosis 1

Severe Phenotype in Patients with Large Deletions of NF1

Neurofibromatosis I and multiple sclerosis

Absence of Efficacy of Everolimus in Neurofibromatosis 1-Related Plexiform Neurofibromas: Results from a Phase 2a Trial

Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation

Segmental schwannomatosis: characteristics in 12 patients

What is the reliability of non-trained investigators in recognising structural MRI lesions of sacroiliac joints in patients with recent inflammatory back pain? Results of the DESIR cohort

Clinical Characteristics of Pruritus in Neurofibromatosis 1

NF1 single and multi-exons copy number variations in neurofibromatosis type 1

Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort

NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience

Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort

At-risk phenotype of neurofibromatose-1 patients: a multicentre case-control study

Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1

NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1

NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype

Lower Prevalence of Overweight and Obesity in Adults with Neurofibromatosis

In-Hospital Clinical Features, Morbidity, and Mortality of Patients with Neurofibromatosis 1 in France: A Nationwide, Population-Based Retrospective Cohort Study

Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France

Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1

Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1

Whole-Body Positron Emission Tomography with (18)F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1

Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohort

Can power Doppler ultrasound of the entheses help in classifying recent axial spondyloarthritis? Data from the DESIR cohort

Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study

Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966